文献速递神经CTMR

中枢神经系统间叶性非脑膜内皮肿瘤:演进的分子景观及对神经放射科医生的意义

Mesenchymal Nonmeningothelial Tumors of the CNS: Evolving Molecular Landscape and Implications for Neuroradiologists.
PubMed 文献 · AJNR Am J Neuroradiol · 2025-05-02

中枢神经系统间叶性非脑膜内皮肿瘤按WHO中枢神经系统肿瘤分类第5版分为软组织、软骨-骨及脊索三类,软组织肿瘤又分纤维母细胞性、血管性和骨骼肌亚型,并新增「分化不确定的肿瘤」亚类,包括FET::CREB融合阳性、CIC重排肉瘤和DICER1突变原发性颅内肉瘤。由于组织学和免疫表型常无特异性,分子技术对准确诊断不可或缺。本文综述其临床、影像、组织病理和分子特征及治疗策略。

要点

  • 这类肿瘤多起源于脑膜,罕见于脑实质,主要位于幕上。
  • WHO中枢神经系统肿瘤分类第5版将「分化不确定的肿瘤」新增为亚类,含三种新的组织分子实体。
  • 组织学和免疫表型常无特异性时,分子技术对准确诊断不可或缺。

核心结论

  • WHO中枢神经系统肿瘤分类第5版修订了中枢神经系统间叶性非脑膜内皮肿瘤的术语和诊断标准,以更好与中枢神经系统外软组织肿瘤分类对齐,分子技术对分化不确定肿瘤的准确诊断不可或缺。

研究设计与样本

  • 综述,系统概述原发中枢神经系统间叶性非脑膜内皮肿瘤的临床、影像、组织病理和分子特征及治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The World Health Organization Classification of Tumors of the Central Nervous System, 5th edition (WHO CNS5) significantly revised the terminology and diagnostic criteria of "mesenchymal nonmeningothelial" tumors of CNS to better align with the classification of these soft tissue tumors outside the CNS. The CNS chapter only covers the entities with distinct histologic or molecular characteristics that occur exclusively or primarily in the CNS. These tumors usually arise from the meninges and are rarely intraparenchymal in origin, mainly in the supratentorial compartment. These tumors are grouped into 3 main categories: soft tissue, chondro-osseous, and notochordal. Soft tissue tumors, the largest group, are further divided into fibroblastic, vascular, and skeletal muscle subtypes. Notably, a new subcategory for "tumors of uncertain differentiation" has been introduced, encompassing 3 new histomolecular entities: FET::cAMP response element-binding protein (CREB) fusion-positive, Capicua transcriptional receptor (CIC)-rearranged sarcoma, and primary intracranial sarcoma, DICER1-mutant. Emerging entities like dural angioleiomyomas and spindle cell neoplasms with neurotrophic receptor kinase (NTRK) rearrangements have been reviewed, although not introduced in WHO CNS5. Given the often nonspecific histology and immunophenotype of mesenchymal nonmeningothelial tumors of uncertain differentiation, molecular techniques have become indispensable for accurate diagnosis. This review provides a comprehensive overview of primary mesenchymal nonmeningothelial CNS tumors, including their clinical, radiologic, histopathologic, and molecular characteristics and treatment strategies.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Soni N, Ora M, Szekeres D, et al. Mesenchymal Nonmeningothelial Tumors of the CNS: Evolving Molecular Landscape and Implications for Neuroradiologists. AJNR Am J Neuroradiol. 2025. PMID: 39349307. doi:10.3174/ajnr.A8519

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。